Abbott Takes On Facet
Drug and medical products company Abbott Laboratories said Tuesday it will buy Facet Biotech Corp. for about $450 million in cash, expanding the company's access to biotechnology drugs, including a potential treatment for multiple sclerosis.Facet and its partner Biogen Idec plan to move the...
Abbott Takes On Facet
Big pharma firm wins bid for a promising pipeline of multiple sclerosis, oncology drugs.
Fri 12 Mar 10 from CandEN
Abbott to pay $450 million for Facet Biotech
Drug and medical products company Abbott Laboratories said Tuesday it will buy Facet Biotech Corp. for about $450 million in cash, expanding the company's access to biotechnology drugs, including ...
Tue 9 Mar 10 from R&D Mag
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
ABBOTT PARK, Ill. and REDWOOD CITY, Calif., March 9 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Facet Biotech Corporation (Nasdaq: FACT) announced today a definitive agreement for Abbott ...
Tue 9 Mar 10 from RedOrbit
- Pages: 1
Bookmark
